After three years of clinical and laboratory research at gastroenterology and liver diseases research center of Tehran university of medical sciences, a highly effective drug against hepatitis C has been produced under the brand name Sovodak. During a period of less than three months, it treats hepatitis C in more than 98% of patients with using one pill per day. The other benefits of this drug are the non-concurrent use of an Interferon drug, its effectiveness on all hepatitis C virus genotypes, its effectiveness on advanced cases (cirrhosis) or patients who have not responded to other medications and no significant side effects.
June 1, 2019
June 27, 2019